← Eichor
Study identifier: NCT07518576 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Development and Validation of Language and Communication Assessment Scales

Condition: Language Disorders · Aphasia  ·  Sponsor: IRCCS San Camillo, Venezia, Italy

PhaseN/A
Planned participants50
Who can joinAll sexes, 18 Years to 90 Years
Healthy volunteersNo

About this study

The aim of speech therapy for people with aphasia is to improve their ability to communicate in daily life. Traditional evaluations focus on linguistic tasks, but they do not fully address everyday communication skills, which are crucial for creating personalized treatment goals. The study suggests a multimodal approach to language assessment, stressing the importance of gestures in communication. It calls for the development of tools that evaluate communication in a wider context, including factors like motivation, attention, awareness, and alternative communication strategies. Additionally, there is a need for tools specifically designed to assess communicative gestures.

This description comes directly from the study's public registry record.

Talk to the study team

Sara Nordio, SLP,PhD  ·  3494990310  ·  sara.nordio@hsancamillo.it

Always discuss trial participation with your own doctor first.

Locations (1)

IRCCS San CamilloVenice, VE, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07518576